Health Technology Adil

Adial Pharmaceuticals, Inc

ADIL | News | $1.72 1.18% 1.16% 140K

(0.0% 1d) (25.3% 1m) (402.9% 1y) (0.0% 2d) (0.6% 3d) (-11.4% 7d) (-65.43% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 6,974,361
http://www.adialpharma.com
Sec Filling | Patents | 4 employees

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

alcohol use disorder serotonin-3 msa treatment

add to watch list Paper trade email alert is off

Press-releases

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| -11.4% | O: 4.66% H: 1.49% C: -5.94%
patent granted pharmaceuticals key

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 48.7% | O: 123.48% H: 0.0% C: 0.0%
ad04 alcohol publication treatment pharmaceuticals for trial potential

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04
Published: 2024-04-10 (Crawled : 14:30) - biospace.com/
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 48.7% | O: 123.48% H: 0.0% C: 0.0%
ad04 publication pharmaceuticals trial

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Published: 2024-04-02 (Crawled : 12:30) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 37.9% | O: -3.23% H: 2.5% C: 2.5%
business year update pharmaceuticals financial results

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Published: 2024-03-02 (Crawled : 00:20) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| Email alert Add to watchlist
million pharmaceuticals

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Published: 2024-02-28 (Crawled : 14:30) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 95.81% | O: 17.94% H: 178.64% C: 57.28%
patent pharmaceuticals

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Published: 2024-02-13 (Crawled : 14:00) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 51.15% | O: 19.33% H: 5.93% C: -8.89%
patent pharmaceuticals

Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Published: 2024-01-18 (Crawled : 13:30) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 26.38% | O: 3.47% H: 2.86% C: -7.05%

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
Published: 2023-12-20 (Crawled : 14:00) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology

| 1.18% | O: 10.65% H: 5.35% C: -7.48%
payment pharmaceuticals

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
Published: 2023-11-29 (Crawled : 22:00) - adialpharma.com
ADIL | News | $1.72 1.18% 1.16% 140K

Health Technology